Showing results (271-280 of 381) with videos related to
Sort By:
Pageof 39
Nature Communications|June 17, 2022
FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusionShuaifeng Li, Shixun Han, Qi Zhang, et al.Cell Research|August 15, 2015
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesisShuying Shen, Xiaocan Guo, Huan Yan, et al.Cell Stem Cell|October 23, 2024
Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in miceRong Mou, Junkai Ma, Xuan Ju, et al.Science Advances|May 21, 2025
Sphingolipid synthesis in tumor-associated macrophages confers immunotherapy resistance in hepatocellular carcinomaXiaozhen Zhang, Mengyi Lao, Kang Sun, et al.Annals of Surgical Oncology|April 13, 2023
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 TrialQihan Fu, Yiwen Chen, Dabing Huang, et al.International Journal of Cancer|September 12, 2025
Preoperative prediction of early recurrence in pancreatic cancer: A novel clinical-radiomics modelYiting Xu, Ming Chen, Yang Chen, et al.Cell Reports|June 28, 2023
Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferationTao Wei, Jin Li, Jian Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2022
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2Wen Chen, Liang Wen, Yingying Bao, et al.Clinical and Translational Medicine|June 23, 2020
Contrast-enhanced CT radiomics for preoperative evaluation of microvascular invasion in hepatocellular carcinoma: A two-center studyXiuming Zhang, Shijian Ruan, Wenbo Xiao, et al.Cell Death and Differentiation|December 20, 2022
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancerHanshen Yang, Xiaozhen Zhang, Mengyi Lao, et al.Pageof 39